![Louis Matis](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Louis Matis
Plus aucun poste en cours
Historique de carrière de Louis Matis
Anciens postes connus de Louis Matis
Sociétés | Poste | Début | Fin |
---|---|---|---|
PIERIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 18/08/2015 | 10/01/2020 |
Immune Tolerance Institute, Inc.
![]() Immune Tolerance Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Part of The David H. Murdock Research Institute, Immune Tolerance Institute, Inc. provides integrated, state-of-the-art genomic, cellular, proteomic and bioinformatics technology platforms. The company is based in Menlo Park, CA. Immune Tolerance Institute was acquired by The David H. Murdock Research Institute on June 09, 2011. | Directeur Général | 01/01/2007 | 01/01/2010 |
Gilead Connecticut, Inc.
![]() Gilead Connecticut, Inc. Pharmaceuticals: MajorHealth Technology Gilead Connecticut, Inc. manufactures pharmaceuticals and biotechnology chemicals. The firm develops a pipeline of small molecule therapeutics for multiple oncology and immunology-based indications. It focuses on the development of novel kinase inhibitors for the treatment of cancer, autoimmune, and inflammatory diseases. The company was founded in 2000 and is headquartered in Foster City, CA. | Directeur Général | 01/09/2000 | 01/01/2006 |
President | 01/09/2000 | 01/01/2006 | |
National Cancer Institute
![]() National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | - | - |
ALEXION PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 01/01/1993 | - |
Formation de Louis Matis
Amherst College | Undergraduate Degree |
Perelman School of Medicine | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 8 |
Opérationnelle
Chief Executive Officer | 2 |
Corporate Officer/Principal | 2 |
President | 1 |
Sectorielle
Health Technology | 4 |
Consumer Services | 3 |
Miscellaneous | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
PIERIS PHARMACEUTICALS, INC. | Health Technology |
Entreprise privées | 4 |
---|---|
Gilead Connecticut, Inc.
![]() Gilead Connecticut, Inc. Pharmaceuticals: MajorHealth Technology Gilead Connecticut, Inc. manufactures pharmaceuticals and biotechnology chemicals. The firm develops a pipeline of small molecule therapeutics for multiple oncology and immunology-based indications. It focuses on the development of novel kinase inhibitors for the treatment of cancer, autoimmune, and inflammatory diseases. The company was founded in 2000 and is headquartered in Foster City, CA. | Health Technology |
Alexion Pharmaceuticals, Inc.
![]() Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
National Cancer Institute
![]() National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Miscellaneous |
Immune Tolerance Institute, Inc.
![]() Immune Tolerance Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Part of The David H. Murdock Research Institute, Immune Tolerance Institute, Inc. provides integrated, state-of-the-art genomic, cellular, proteomic and bioinformatics technology platforms. The company is based in Menlo Park, CA. Immune Tolerance Institute was acquired by The David H. Murdock Research Institute on June 09, 2011. | Commercial Services |
- Bourse
- Insiders
- Louis Matis
- Expérience